AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitadoc M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Elbrit Life Sciences

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitadoc M 50mg/500mg Tablet

Diabetic patients with type 2 mellitus may be prescribed the dual-action Metformin/Sitagliptin 50mg/500mg tablet to manage elevated blood glucose. This treatment helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. This medication might be used independently or in conjunction with other anti-diabetic therapies. Optimal efficacy is achieved through concurrent lifestyle modifications including a balanced diet and regular physical activity. Dosage is individualized based on the patient's health status, glycemic control, and other medications. Ingesting the tablet with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when used with insulin or sulfonylureas; proper recognition and management of hypoglycemia are essential. This medication is not universally suitable. Prior to initiating treatment, inform your physician of any pre-existing renal, hepatic, or cardiac conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should consult their physician before commencing treatment. Interactions with other medications are possible; disclose all current medications to ensure treatment safety. Alcohol intake should be minimized due to its potential to exacerbate hypoglycemia. Regular monitoring of renal function and blood glucose levels will be conducted throughout treatment.

Uses of Sitadoc M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitadoc M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Sitadoc M 50mg/500mg tablets with a meal.

Common Side effects of Sitadoc M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitadoc M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Sitadoc M 50mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Sitadoc M 50mg/500mg Tablet works:

Sitagliptin/metformin 50mg/500mg tablets (Sitadoc M) combine two distinct medications to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitadoc M 50mg/500mg Tablet with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitadoc M 50mg/500mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Sitadoc M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Sitadoc M 50mg/500mg tablets, as dose modification may be necessary. Consultation with a physician is recommended. Sitadoc M 50mg/500mg tablets are contraindicated in patients with severe kidney disease. Close monitoring of kidney function is advised during treatment.

LiverLiverUNSAFE

Use of Sitadoc M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Sitadoc M 50mg/500mg Tablet :

Should you forget a dose of Sitadoc M 50mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitadoc M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitadoc M 50mg/500mg Tablet

Sitadoc M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitadoc M 50mg/500mg Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitadoc M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitadoc M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitadoc M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin + Metformin (Sitadoc M 50mg/500mg) can cause lactic acidosis (MALA), a serious medical emergency characterized by excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitadoc M and seek immediate medical attention.
Sitadoc M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Sitadoc M 50mg/500mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitadoc M 50mg/500mg Tablets are contraindicated in patients with known allergies to any component or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitadoc M 50mg/500mg Tablet with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitadoc M 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitadoc M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the label's storage instructions. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitadoc M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Sitadoc M 50mg/500mg Tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitadoc M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitadoc M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitadoc M 50mg/500mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Sitadoc M and seek immediate medical attention.
Prolonged use of Sitadoc M 50mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely and ensure it's inaccessible to children, pets, and others.
Sitadoc M 50mg/500mg Tabl...
168
MRP 195
13% off